SGMT: Sagimet Biosciences Inc. Stock

by  •  • Comments Off on SGMT: Sagimet Biosciences Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 96.63
Enterprise Value ($M) 19.87
Book Value ($M) 155.81
Book Value / Share 5.08
Price / Book 0.61
NCAV ($M) 148.32
NCAV / Share 4.84
Price / NCAV 0.65

Profitability (mra)
Return on Invested Capital (ROIC) -0.29
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 34.30
Current Ratio 34.30

Balance Sheet (mrq) ($M)
Current Assets 152.77
Assets 160.26
Liabilities 4.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -54.45
Net Income -45.57

Cash Flow Statement (mra) ($M)
Cash From Operations -42.44
Cash from Investing -61.68
Cash from Financing 104.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Blue Owl Capital Holdings LP 4.32 -20.91
11-14 13G/A Point72 Asset Management, L.P. 8.00 53.05
11-14 13G/A Baker Bros. Advisors Lp 4.99 5.63
11-14 13G/A Hillhouse Capital Management, Ltd. 2.40 -50.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 134,590 457,145 29.44
2025-04-24 269,844 978,444 27.58
2025-04-23 151,297 674,747 22.42
2025-04-22 296,982 871,656 34.07

(click for more detail)

Similar Companies
RYTM – Rhythm Pharmaceuticals, Inc. SAGE – Sage Therapeutics, Inc.
SCYX – SCYNEXIS, Inc. SIGA – SIGA Technologies, Inc.
SKYE – Skye Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io